A proposed new therapeutic protocol for the treatment of canine mange with ivermectin

Journal of the American Animal Hospital Association

Volumn 35, Issue 1, 1999, Pages 77-80

  Mueller, Ralf S ^a   Bettenay, Sonya V ^a  

^a Animal Skin and Allergy Clinic   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRAZ; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; IVERMECTIN; LINCOMYCIN; MILBEMYCIN;

ARTICLE; ATAXIA; CLINICAL PROTOCOL; DIAGNOSTIC APPROACH ROUTE; DOG; DRUG MONITORING; FEMALE; MALE; MYDRIASIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PYODERMA; SCABIES; TREMOR;

ATAXIA; CANIS FAMILIARIS;

EID: 0032945743     PISSN: 05872871     EISSN: None     Source Type: Journal    
DOI: 10.5326/15473317-35-1-77     Document Type: Article

References (16)

1. Scheidt VJ, Medleau L, Seward RL, Schwartzman RM. An evaluation of ivermectin in the treatment of sarcoptic mange in dogs. Am J Vet Res 1984;45:1201-2.
2. Scott DW, Miller WH, Griffin CE. Canine scabies. In: Scott DW, Miller WH, Griffin CE, eds. Small animal dermatology. 5th ed. Philadelphia: WB Saunders, 1995:417-32.
3. Fondati A. Efficacy of daily oral ivermectin in the treatment of 10 cases of generalized demodicosis in adult dogs. Vet Derm 1997;7:99-104.
4. Medleau L, Ristic Z, McElveen DR. Daily ivermectin for the treatment of generalized demodicosis in dogs. Vet Derm 1996;7:209-12.
5. Guaguere E. Traitement de la demodecie generalisee du chien par l'ivermectine: a propos de 20 cas. Prat Med Chir Anim Comp 1996;31:33-40.
6. Pullam JD, Seward RL, Henry RT, Steinberg A. Investigating ivermectin toxicity in collies. Vet Med 1985;80:33-40.
7. Houston DM, Parent J, Matushek KJ. Ivermectin toxicosis in a dog. J Am Vet Med Assoc 1987;191:78-80.
8. Paul AJ, Tranquilli WJ, Seward RL, Todd KS, DiPietro JA. Clinical observations in collies given ivermectin orally. Am J Vet Res 1987;48: 684-5.
9. Hopkins KD, Marcella KL, Strecker AE. Ivermectin toxicosis in a dog. J Am Vet Med Assoc 1990;197:93-4.
10. Campbell WC, Fisher MH, Stapley EQ, et al. Ivermectin - a potent new antiparasitic agent. Science 1983;221:823-8.
11. Bennett DG. Clinical pharmacology of ivermectin. J Am Vet Med Assoc 1986;189:100-4.
12. Arena JP, Liu KK, Paress PS, Schaeffer JM, Cully DF. Expression of a glutamate-activated chloride current in xenopus oocytes injected with Caenorhabditis elegans RNA: evidence for modulation with avermectin. Mol Brain Res 1992;15:339-48.
13. Arena JP, Liu KK, Paress PS, et al. The mechanism of action of avermectins in Caenorhabditis elegans: correlation between activation of glutamate-sensitive chloride current, membrane binding and biological activity. J Parasitol 1995;81:286-94.
14. Campbell WC, Benz GW. Ivermectin: a review of efficacy and safety. J Vet Pharmacol Ther 1984;7:1-16.
15. Fassler PE, Tranquilli WJ, Paul AJ, Soll MD, DiPietro JA, Todd KS. Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin sensitive collies. J Am Vet Med Assoc 1991;199:457-60.
16. Lo P-KA, Fink DW, Williams JB, Blodinger J. Pharmacokinetic studies of ivermectin: effects of formulation. Vet Res Commun 1985;9:251-68.